CAS: 6745-93-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Methotrexate REF: 4Z-M-701CAS: | - - - | A consultar | Vie 13 Dic 24 |
 | Methotrexate monohydrate REF: TM-T28027CAS: 6745-93-3 | - - - | 1.576,00 €~2.643,00 € | Jue 19 Dic 24 |
 | N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methyl- amino]benzoyl]-L-glutamic acid REF: 3D-GAA74593CAS: 6745-93-3 | Min. 95% | A consultar | Jue 23 Ene 25 |
Ref: 4Z-M-701
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 13 de Diciembre de 2024
Methotrexate monohydrate
CAS:6745-93-3
Methotrexate monohydrate inhibits DHFR, enhances T cell apoptosis, reduces activation, and suppresses cytokines.
Fórmula:
C20H24N8O6
Forma y color:
Solid
Peso molecular:
472.45
Ref: TM-T28027
| 25mg | 1.576,00 € | ||
| 50mg | 2.057,00 € | ||
| 100mg | 2.643,00 € |
Entrega estimada en Estados Unidos, el Jueves 19 de Diciembre de 2024
![N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methyl- amino]benzoyl]-L-glutamic acid](https://static.cymitquimica.com/products/3D/thumb/GAA74593.jpg)
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methyl- amino]benzoyl]-L-glutamic acid
CAS:6745-93-3
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid is a kinase inhibitor that has been shown to induce apoptosis in cancer …
Fórmula:
C20H24N8O6
Pureza:
Min. 95%
Peso molecular:
472.5 g/mol
Ref: 3D-GAA74593
| 250mg | A consultar | ||
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 23 de Enero de 2025
